Recorded: 29 May 2008
Well, I guess stem cells in biology are very important to any event or regeneration, the normal development of organisms, but also cancer, obviously. There is a certain hype going on in the last few years, I think, particularly in the U.S., much less so in Europe, over stem cells, the science of stem cells, the ethics of stem cells, driven also in part by all the development we’ve seen recently. So in that sense I think this meeting’s great, because it brings together a lot of the scientists from all these different fields of stem cells. So we’ll discuss science, but also discuss ethics.
Have I heard anything new at this meeting? I will say there are so many stem cell meetings at the moment, I just was in—yesterday I was in Boston at another stem cell meeting. And the field, it’s interesting to see how well it integrates and how dynamic it is. So most of the speakers here I’ve seen within the last three or four months somewhere on the globe. So I guess it’s—for us it’s good to sit down and discuss experiments between the talks, and I think the talks have more--perform the function for the PhD students and the post-docs.
Yeah, I think there’s a few, well, particularly in my field where little details of the last few months would matter. So, in my field is the gut, but other tissues are very similar, the pancreas, the skin, the brain, so there’s a number of talks going to be on in the next few days, where maybe some new little breakthroughs are being announced.
Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA.
From 1991-2002 Hans Clevers was Professor in Immunology at the University Utrecht and, since 2002, Professor in Molecular Genetics. Since 2002, he is director of the Hubrecht Institute in Utrecht.
Hans Clevers has been a member of the Royal Netherlands Academy of Arts and Sciences since 2000 and is the recipient of several awards, including the Dutch Spinoza Award in 2001, the Swiss Louis Jeantet Prize in 2004, the Memorial Sloan-Kettering Katharine Berkan Judd Award in 2005, the Israeli Rabbi Shai Shacknai Memorial Prize in 2006, and the Dutch Josephine Nefkens Prize for Cancer Research and the German Meyenburg Cancer Research Award in 2008. He obtained an ERC Advanced Investigator grant in 2008. He is Chevalier de la Legion d'Honneur since 2005.